View
216
Download
3
Embed Size (px)
WOUNDHEALINGPRODUCTSFormularyandGuidelines2012WoundHealingGroupAneurinBevanUniversityHealthBoardThisGuidelines/Formularyisavailableonlineat:www.gpmtc.wales.nhs.uk
TheuseofwoundhealingproductsinbolditalicsarerestrictedandrequireauthorizationseeTABLES1to3AneurinBevanUniversityHealthBoardWoundHealingGuidelines&FormularyFOURTHEDITIONMay2012(RevisedNov2013)Reviewdate:2015 2
Contents
A.IntroductionPage3B.WoundManagementGuidelinesPage46C.FormularyPage714D.GuidanceontheuseofSilverDressingsPage15E.GuidanceontheuseofSiliconedressingsPage16F.GuidanceontheuseofTNPPage17G.ReferencesandFurtherGuidancePage18H.WoundHealingProductsPage19I.CNSTissueViabilitycontactdetailsPage20
TheuseofwoundhealingproductsinbolditalicsarerestrictedandrequireauthorizationseeTABLES1to3AneurinBevanUniversityHealthBoardWoundHealingGuidelines&FormularyFOURTHEDITIONMay2012(RevisedNov2013)Reviewdate:2015 3
A.INTRODUCTIONThis formulary provides information on a definitive list of dressings which will beavailablewithin theAneurinBevanUniversityHealthBoardandprovidesguidanceontheiruse.ThisisacollaborativedocumentacrossPrimaryandSecondaryCare.The information has been collated by themembers of theWound FormularyGroupwhosemembersincludethefollowing:DrRichardGoodwin ChairConsultantDermatologistJayneWarren CNSTissueViabilityTraceyMorgan CNSTissueViabilityAlisonChandler CNSTissueViabilityLizJeffreys FootandAnkleNurseSpecialistTrevorBatt PrincipalPharmacistFormulary/InterfaceCharmaineJuniper PrescribingSupportPharmacistCaerphillyLocalityTraceyHutchings CNSVascularSurgeryTheresaMaclean PharmacistRGHGaynorSlocombe PodiatristLizFreeman CNSDermatologyThereareawiderangeofproducts included intheformularywhichareappropriatefor specific stagesofwoundhealing. Inexceptional circumstanceswhere a suitabledressing cannot be found on the Formulary an application for dressings orwoundproductsnot listedcanbemadevia thechairmanof theWoundHealingGroup,Dr.RichardGoodwinConsultantDermatologist,orinhisabsenceaCNSinTissueViability.N.B.Dressings listed inTable2areonlyavailable ifauthorisedbytheCNSTissueViabilityor Community Band 7+. All woundsmust be assessed and an authorisation formcompletedpriortoapplicationandplacedinpatientsnotes.DressingslistedinTable3areonlyavailableifauthorisedbyCNSinTissueViabilityandanauthorisationformiscompletedpriortoapplicationandplacedinpatientsnotes
TheuseofwoundhealingproductsinbolditalicsarerestrictedandrequireauthorizationseeTABLES1to3AneurinBevanUniversityHealthBoardWoundHealingGuidelines&FormularyFOURTHEDITIONMay2012(RevisedNov2013)Reviewdate:2015 4
B.WOUNDMANAGEMENTGUIDELINESTheseguidelineshavebeenwrittentoassiststaffinthemanagementofwounds.Itisfundamentaltowoundmanagementthatathoroughassessmentofeachpatientisundertakenpriortodevelopingamanagementplanforanywound.Theaimsandobjectivesoftheseguidelinesare:
Patientassessment
Woundassessment
Treatment/DressingSelection
Patientadvocate
Recordinginformation
Reviewdate
Patientdischargeinformation
PatientAssessment
Thisshouldcomprise:
Chronicdisease
Nutritionalstatus
Immunestatus
Age
Psychologicalstatus
Smoking
Currentandrelevantpreviousmedication
Relevantbloods
SocialFactors
TheuseofwoundhealingproductsinbolditalicsarerestrictedandrequireauthorizationseeTABLES1to3AneurinBevanUniversityHealthBoardWoundHealingGuidelines&FormularyFOURTHEDITIONMay2012(RevisedNov2013)Reviewdate:2015 5
WoundAssessment
Thisshouldinclude: Previoushistoryand treatmentobtained from thepatient ifnot recorded in
thenotesorreferralletter Wound aetiology Vascular assessment including Ankle Brachial Pressure
Index.Neurological assessmentwhere possible to establish the presence ofneuropathy.Itisparamountthatallpossiblecausativefactorsareinvestigatedandifnecessaryanappropriatereferralismadetotherelevantspecialism
Number,sizeandlocationofallwounds. PressureUlcerGradeEPUAP(2009) Typeandappearanceofwound,e.g.colour,tissue,exudateetc Patientsnormalrestingpositioninrelationtothewounde.g.legelevation Pain The alleviation of pain should be promptly addressed and carefully
monitored. AppearanceofsurroundingskinSkinCareEmollients(suchasemulsifying
ointmentBP)areusedtoincreaseskinhydrationandtohelppreventthedevelopmentofeczemaanddrycracksandfissuresonfeet.SeeABHBMedicinesFormularyforfurtherinformationonspecificemollientchoices.
WaterlowAssessment. SkinBundleimplementedifindicated. WoundChartcompleted.
Treatment/DressingSelection
ReferencetotheWoundHealingGroupFormularyisessential.Forproductsintable2and3pleasecontactappropriatepersonnel
To optimise healing in the majority of wounds a moist environment is
desirable. This encourages the breakdown of fibrin and dead tissue andpreventstissuedehydration.Italsopromotestheinteractionofgrowthfactorswhich results in formation of new capillaries and new granulation tissue.However patients with Peripheral Vascular Disease with wounds on theirextremities should not be treated with autolytic debriding agents. THESEWOUNDSSHOULDBEKEPTDRY
TheuseofwoundhealingproductsinbolditalicsarerestrictedandrequireauthorizationseeTABLES1to3AneurinBevanUniversityHealthBoardWoundHealingGuidelines&FormularyFOURTHEDITIONMay2012(RevisedNov2013)Reviewdate:2015 6
There is no such thing as an ideal dressing. Dressing selected should include thefollowingcharacteristics:
Maintainamoistenvironment
Adequatelymanageexcessexudate
Allowgaseousexchange
Providethermalinsulationandmechanicalprotection
Nonallergicandnonsensitising
Impermeabletomicroorganisms
Acceptabletopatientandpainminimising
Clinically/costeffective
Noninflammable
Nonadherent
Patientengagementandcommunication
Thisisakeyroleforanyhealthprofessionaltreatingapatient.Anexplanationofthenatureandtypeofwound,andtheexpectedactionsoftheselecteddressingshouldbe conveyed to the patient. It is essential to obtain informed consent from thepatientor their legalrepresentativeprior toany intervention.Thismustbeclearlydocumented in thepatients records. Itmustbe clear that the treatmentoptions,expectedoutcomes,anypossibleadverseeventsandalternativestothesuggestedtreatmentareexplainedandunderstoodbythepatientortheirlegalrepresentative.It is essential that the level of concordance of the patient to a proposedtreatment/managementplanisestablishedasthiswillinfluencetheeffectivenessoftheplan.
RecordingInformation
TheABHBWoundManagementChartshouldbecompletedtorecordallinformationrelating towoundmanagement. It isa legal requirement thatall interventionsarefullydocumentedinthepatientstreatmentrecorde.g.medicalnotes,nursingnotesorpatientrecords.
ReviewDateAdateforreassessmentshouldbeagreedwiththenurse/doctor.
PatientDischargeInformation
Ifapatientisadmittedtoordischargedfromhospitalwithawound,instructionsshouldbeprovidedontheplanofcareandawoundchartcompleted.
TheuseofwoundhealingproductsinbolditalicsarerestrictedandrequireauthorizationseeTABLES1to3AneurinBevanUniversityHealthBoardWoundHealingGuidelines&FormularyFOURTHEDITIONMay2012(RevisedNov2013)Reviewdate:2015 7
C.FORMULARYToassist in thecorrectselectionofwounddressing this formularyhasbeendesignedaroundthetypeofwoundratherthan individualdressings.Afterreadingthe WoundManagementGuidelinestheclinicianshouldconsulttheformularysection.Note:Productslistedinbolditalicsareforrestricteduseonly.Woundtypeclassifications:
1.InflamedFoot
2.EpithelialisingWounds
2.1Superficial,clean,lowexudate2.2Clean,withmediumexudate
3.GranulatingWounds
3.1Clean,surgicalwoundswithtissueloss3.2Chronicwoundswithlow/moderateexudate3.3Chronicopenwoundswithmoderate/highexudate3.4Chroniccavitywounds
4.Woundswithslough
4.1Dry4.2Moist4.3Cavities
5.BlackNecroticWounds
5.1Superficial4.2Extensiveanddeep
6.InfectedandMalodorousWounds
6.1Shallow6.2Cavities6.3Heavyexudate6.4Malodorous
7.Miscellaneous
7.1Miscellaneousforgeneraluse7.2Miscellaneousforrestricteduse
TheuseofwoundhealingproductsinbolditalicsarerestrictedandrequireauthorizationseeTABLES1to3AneurinBevanUniversityHealthBoardWoundHealingGuidelines&FormularyFOURTHEDITIONMay2012(RevisedNov2013)Reviewdate:2015 8
1.InflamedFootListedbelowareseveralcommonlyseencausesofthiscondition: Cellulitis(Infection) Eczema can cause a similar appearance (i.e. from venous stasisor contact
sensitivitytodressings) Venoushypertension Ischaemia
Cellulitis is usually preceded 6 to 12 hours by a feeling ofmalaise and flulikesymptoms,withorwithoutpyrexia.Therednesswilloftenspreadvisiblyover24hours.BloodtestsforelevatedCRP,ESRandWhiteCellcountshouldbetaken.Treatmentrequiressystemicantibioticsandlegelevation.Thisconditionisrarelybilateralandotherconditionsshouldbeconsidered.
Eczemaonthefootorlowerlegmaysometimeslookverysimilartocellulitis,butdoes not cause symptoms of malaise or pyrexia. It is commonly caused byvenous stasis. Occasionally an allergic contact dermatitis to topically appliedmedications,dressingsorbandagesmaybe responsible.Treatmentofeczemarequires leg elevation and or compression bandaging as well as topicalemollients and topical steroid. If allergic contact dermatitis is suspected thenpatchtestswillberequiredtodetermineexactlywhichproductisresponsible.
VenousHypertensionmayhaveasimilarpresentationtocellulitisandcanpresentbilaterally. If the patients general medical condition permits, compressiontherapyshouldbeconsidered.
Ischaemiaclassicallypresentsasverypainful(RestPainonelevation)andabsentfootpulses.
Theuseofwoundhealingproductsinbolditalicsare